Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MTFB.L (MTFB) Regulatory News

Date Source Headline
24th Jun 2019 7:00 am RNS Motif Bio Presents New Iclaprim Data - ASM Microbe
20th Jun 2019 4:35 pm RNS Price Monitoring Extension
19th Jun 2019 5:08 pm RNS Holding(s) in Company
18th Jun 2019 4:05 pm RNS Holding(s) in Company
14th Jun 2019 9:04 am RNS Holding(s) in Company
12th Jun 2019 5:52 pm RNS Holding(s) in Company
6th Jun 2019 7:00 am RNS Receipt of FDA Meeting Minutes
31st May 2019 3:15 pm RNS Result of AGM
31st May 2019 10:28 am RNS Holding(s) in Company
29th May 2019 11:36 am RNS Holding(s) in Company
22nd May 2019 1:50 pm RNS AGM Statement
22nd May 2019 7:00 am RNS Orphan Disease Opportunity for Iclaprim
21st May 2019 7:00 am RNS Iclaprim Data presented at ASM Microbe 2019
20th May 2019 6:14 pm RNS Holding(s) in Company
3rd May 2019 6:25 pm RNS Meeting with US FDA held as planned
1st May 2019 7:00 am RNS Motif Signs Agreement with Lamellar Biomedical
26th Apr 2019 7:01 am RNS Notice of AGM
26th Apr 2019 7:00 am RNS Appointment of Andrew Powell to Board of Directors
16th Apr 2019 7:00 am RNS Motif Presents New Iclaprim Data at ECCMID 2019
15th Apr 2019 7:00 am RNS Fiscal Year 2018 Results
4th Apr 2019 7:00 am RNS Motif Bio to Present Iclaprim Data at ECCMID 2019
2nd Apr 2019 5:43 pm RNS Holding(s) in Company
1st Apr 2019 3:28 pm RNS Holding(s) in Company
1st Apr 2019 2:17 pm RNS Holding(s) in Company
26th Mar 2019 7:00 am RNS Motif Bio Raises £2.7m (US$3.55m)
25th Mar 2019 9:49 am RNS Proposed Equity Fundraise
20th Mar 2019 7:00 am RNS Holding(s) in Company
20th Mar 2019 7:00 am RNS Motif Bio Granted Meeting with U.S. FDA
18th Mar 2019 7:00 am RNS Appointment of Bruce Williams as Interim Chairman
15th Mar 2019 7:01 am RNS Holding(s) in Company
7th Mar 2019 12:07 pm RNS Second Price Monitoring Extn
7th Mar 2019 12:02 pm RNS Price Monitoring Extension
19th Feb 2019 7:00 am RNS Conference Call and Webcast
18th Feb 2019 7:00 am RNS Amendment Agreement with Hercules Capital
15th Feb 2019 4:28 pm RNS Holding(s) in Company
15th Feb 2019 4:26 pm RNS Holding(s) in Company
14th Feb 2019 7:00 am RNS Complete Response Letter from the FDA
5th Feb 2019 7:00 am RNS Exercise of Warrants
23rd Jan 2019 4:31 pm RNS Exercise of Warrants
1st Nov 2018 4:40 pm RNS Second Price Monitoring Extn
FTSE 100 Latest
Value8,809.74
Change53.53